Urology Research at the Michigan Institute of Urology

 


Interstim

Interstim Therapy - Sacral Nerve Stimulation

Sacral nerve stimulation is the only intervention that addresses the nerve component of urinary control. InterStim Therapy is intended for patients who have failed or could not tolerate more conservative treatments.

About Sacral Nerve Stimulation

Millions of patients experience bladder control problems, including urinary urge incontinence, non-obstructive urinary retention, and significant symptoms of urgency-frequency.

Medtronic offers an innovative intervention for overactive bladder and urinary retention called sacral nerve stimulation (InterStim® Therapy) in patients who have failed or could not tolerate more conservative treatments. The intervention provides urinary control therapy that addresses the nerve component of bladder control problems.
  • Over 55,000 patients have received sacral nerve stimulation worldwide*
  • Minimally invasive test & implant procedure
  • Over 11 years being FDA approved
  • Proven efficacy in patients for whom more conventional therapy has been unsatisfactory

Indications

Sacral nerve stimulation (InterStim® Therapy) is indicated for patients who haven't had success with urinary control medication, and who suffer from one or more of the following conditions:

  • Urinary urge incontinence
  • Urinary urgency-frequency
  • Non-obstructive urinary retention



Associated Conditions
Interstitial Cystitis Neurogenic Bladder
Overactive Bladder Pelvic Pain
Urinary Incontinence  

Associated Treatments
Neuromodulation  

Products and Resources - Rx

General Adult Urology

BPH (Benign Prostatic Hyperplasia) Drugs

Erectile Dysfunction

Low Testosterone

Minimally Invasive Technologies for Benign Prostatic Hyperplasia (BPH)

NOTE: This information is not intended to substitute for a consultation with a urologist. It is offered to educate the patient and his or her family on the basis of urology conditions in order to get the most out of their office visits and consultations. Please see our disclaimer for additional information.